Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 260
Filter
1.
Breast Dis ; 42(1): 325-330, 2023.
Article in English | MEDLINE | ID: mdl-37899052

ABSTRACT

BACKGROUND: Fibroadenomas are the most common benign breast lesions in women. They present as a unilateral mass and can rapidly enlarge in size through hormonal changes. Fibroadenomas could be classified as small or giant, and as simple or complex. They are classified as 'giant' when the size exceeds 5 cm and/or weight 500 gram; and as 'complex' if one of the following characteristics is present: cysts with a size >3 mm, epithelial calcifications, sclerosing adenosis and papillary apocrine metaplasia. Giant fibroadenomas can cause compression of surrounding breast tissue or breast asymmetry, requiring surgical excision in order to preserve a normal breast shape. CASE: A 26-year-old pregnant woman was referred with a palpable mass of her right breast. The mass rapidly increased in size to a diameter of 13 cm during the second trimester of her pregnancy. A tru-cut biopsy confirmed a fibroadenoma. The rapid growth and compression of normal breast tissues indicated a lumpectomy during her pregnancy. The mass was easily excised without any consequences for the pregnancy. Pathological examination showed a complex giant fibroadenoma. CONCLUSION: A unique case of a pregnant woman with rapid progression of a fibroadenoma that met the criteria of a complex and giant fibroadenoma, was presented. This case emphasizes the importance of timely surgical intervention, even during pregnancy, to prevent permanent breast tissue damage.


Subject(s)
Breast Neoplasms , Fibroadenoma , Fibrocystic Breast Disease , Pregnancy , Female , Humans , Adult , Breast Neoplasms/pathology , Pregnant Women , Fibroadenoma/diagnosis , Fibroadenoma/surgery , Fibroadenoma/pathology , Breast/pathology , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/surgery , Fibrocystic Breast Disease/pathology
2.
J Med Case Rep ; 17(1): 197, 2023 May 16.
Article in English | MEDLINE | ID: mdl-37189170

ABSTRACT

BACKGROUND: Diabetic mastopathy is a rare breast condition that occurs in women with poorly controlled diabetes and is characterized by hardening of the breast tissue. The purpose of this case report is to provide an overview of the clinical characteristics and therapeutic principles of this rare disease to support front-line physicians in their crucial activity of case identification. CASE PRESENTATION: A 64-year-old Asian female patient with a history of type II diabetes mellitus was referred to our clinic for an evaluation of a newly discovered breast mass. The patient had been diagnosed with diabetes more than 20 years prior and was being managed with oral hypoglycemic agents. Her past medical history was otherwise unremarkable. Physical examination of the breast revealed a palpable, mobile, and firm mass measuring 6 × 4 cm in the upper quadrant of the right breast. Ultrasound images showed an uneven hypoechoic nodule, BI-RADS 4B. Mammography showed the compact and flaky nature of the two breasts and the heterogeneity of the substantive density increases. The patient's clinical manifestations and imaging findings suggest the possibility of breast cancer. The patient opted for surgical excision of the mass. Through surgery, the mass was completely excised with negative margins. Pathological examination of the mass revealed a proliferation of fibroblastic cells, with an increased nuclear/cytoplasmic ratio, consistent with a diagnosis of diabetic mastopathy. CONCLUSIONS: This case report serves to highlight the importance of recognizing diabetic mastopathy as a possible differential diagnosis of a breast mass in patients with diabetes mellitus. In our patient, early diagnosis and treatment with lumpectomy resulted in a favorable outcome, emphasizing the importance of prompt medical and surgical management. In addition, more research is needed to mine the diagnostic marker of diabetic mastopathy and provide data related to its prognosis.


Subject(s)
Autoimmune Diseases , Breast Diseases , Breast Neoplasms , Diabetes Mellitus, Type 2 , Fibrocystic Breast Disease , Female , Humans , Middle Aged , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis , Fibrocystic Breast Disease/diagnostic imaging , Fibrocystic Breast Disease/surgery , Breast Diseases/diagnostic imaging , Breast Diseases/surgery , Breast Neoplasms/complications , Breast Neoplasms/diagnostic imaging , Mammography , Breast/diagnostic imaging , Breast/pathology , Diagnosis, Differential , Autoimmune Diseases/diagnosis
3.
J Cancer Res Ther ; 19(Supplement): S116-S120, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37147991

ABSTRACT

Background: Distinguishing benign breast diseases (BBDs) from malignant breast diseases is a worrisome entity and should also have knowledge of the pattern of occurrence of the disorders in their geographical location. This research aimed to study the clinical and histopathological pattern of BBD in Indian patients. Materials and Methods: The study was conducted on 153 specimens from lumpectomy, core needle biopsy, and mastectomy. Data regarding patients' age, sex, presenting complaints, duration of the complaints, and history of menstrual cycles and lactation were collected from the biopsy requisition forms and case papers. The tissue bits were processed and stained with hematoxylin and eosin, and a histopathological examination was performed. Results: Most of the patients in the present study were females (n = 151, 98.7%). The mean age of the patients was 30.45 years. Most of the BBD cases (n = 118, 77.14%) were benign, of which fibroadenoma (101 cases) accounted for 66%. Majority of the lesions were in the upper outer quadrant (39.22%). Of the 153 cases, 94 cases of fibroadenoma, one case of breast abscess, nine cases of fibrocystic change, four cases of phyllodes, three cases of lipoma, and one case of gynecomastia diagnosed clinically correlated well with histopathology (n = 112, 73%). Conclusion: BBDs are mostly seen in female patients in the age group of 21-30 years. Fibroadenoma is the most common BBD. Clinical assessment followed by histopathological examination provided an accurate diagnosis. The clinical diagnosis correlated well with histopathology.


Subject(s)
Breast Diseases , Breast Neoplasms , Fibroadenoma , Fibrocystic Breast Disease , Male , Humans , Female , Young Adult , Adult , Breast Neoplasms/diagnosis , Breast Neoplasms/surgery , Breast Neoplasms/epidemiology , Fibroadenoma/diagnosis , Fibroadenoma/surgery , Tertiary Care Centers , Mastectomy , Breast Diseases/diagnosis , Breast Diseases/surgery , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/surgery , Fibrocystic Breast Disease/epidemiology
4.
Trop Doct ; 53(3): 396-397, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37113077

ABSTRACT

Fibrocystic disease of breast is characterized by lumpiness and discomfort. Our 48-year-old perimenopausal patient had a painless progressively enlarging non-tender lump in her right breast since 1 year. On physical examination a 10 × 8 cm firm non-tender lump was observed occupying almost the whole breast, whose surface was nodular though not fixed. The operative specimen appeared like a honeycomb with multiple cavities filled with yellowish firm material typical of tuberculosis. Surprisingly, histology found neither this nor malignancy. Radical breast excision is never warranted except if the latter is confirmed.


Subject(s)
Fibrocystic Breast Disease , Tuberculosis , Female , Humans , Middle Aged , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/surgery , Fibrocystic Breast Disease/pathology
6.
Pathol Int ; 72(6): 343-348, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35512568

ABSTRACT

Acinic cell carcinoma (AcCC) of breast is a rare subtype of triple-negative breast carcinoma demonstrating a wide morphologic spectrum. In this study, we perform a detailed morphologic and immunohistochemical description of two cases of the rare entity and review the published relative literature. Histologically, the two cases both showed predominantly microglandular and solid structures overlapping with the histological features of microglandular adenosis (MGA), and one case presented spindle cell metaplastic carcinoma with chondromyxoid matrix as a minor morphologic pattern. In two cases, most of the cancer cells were positive for lysozyme and antitrypsin strongly and extensively, but negative for estrogen receptor (ER), progesterone receptor (PR), androgen receptors (AR) and human epidermal growth factor receptor 2 (HER2). The true relationship between breast AcCC and MGA or carcinoma arising in MGA(CAMGA) may remain unclear; re-excision is advised when the MGA-like content extends to the surgical margins in the setting of breast AcCC. More cases and further molecular investigations are required to elucidate the true histogenesis and give the patients appropriate treatment.


Subject(s)
Breast Neoplasms , Carcinoma, Acinar Cell , Carcinoma , Fibrocystic Breast Disease , Triple Negative Breast Neoplasms , Breast Neoplasms/pathology , Carcinoma/pathology , Carcinoma, Acinar Cell/diagnosis , Carcinoma, Acinar Cell/pathology , Female , Fibrocystic Breast Disease/metabolism , Fibrocystic Breast Disease/pathology , Fibrocystic Breast Disease/surgery , Humans , Immunohistochemistry , Triple Negative Breast Neoplasms/pathology
9.
Breast Dis ; 40(3): 207-211, 2021.
Article in English | MEDLINE | ID: mdl-33749635

ABSTRACT

Cysts represent the most common cause of a breast mass in women. On the contrary, in men, the presence of a benign apocrine cyst is an exceedingly rare occurrence, with only a few cases reported in the literature. We describe herein a case of benign apocrine breast cyst without concurrent gynecomastia in a 41-year-old male. Diagnostic evaluation and management are discussed, along with a review of the literature. Given the extreme rarity of benign breast cysts in males, a thorough investigation is essential in male patients presenting with cystic breast lesions. Diagnostic breast imaging may be challenging. Surgical resection of the cyst should be considered in the presence of atypical imaging features to exclude underlying malignancy.


Subject(s)
Breast Cyst/diagnostic imaging , Breast/pathology , Fibrocystic Breast Disease/diagnostic imaging , Gynecomastia/diagnostic imaging , Adult , Apocrine Glands/pathology , Breast/diagnostic imaging , Breast Cyst/surgery , Diagnosis, Differential , Fibrocystic Breast Disease/surgery , Gynecomastia/pathology , Humans , Male , Ultrasonography
10.
Clín. investig. ginecol. obstet. (Ed. impr.) ; 47(2): 69-71, abr.-jun. 2020. ilus, tab
Article in Spanish | IBECS | ID: ibc-193713

ABSTRACT

La mastopatía diabética es una entidad infrecuente. La presentación más común suele ser en forma de nódulo único o múltiple. Sus características clínicas y radiológicas pueden simular un cáncer de mama, por lo que debe tenerse en cuenta este diagnóstico diferencial en las pacientes jóvenes y con antecedentes de diabetes mellitus. Un correcto diagnóstico puede evitar tratamientos quirúrgicos innecesarios. Presentamos 2 casos que hemos diagnosticado en nuestra área sanitaria así como la revisión de la bibliografía al respecto


Diabetic mastopathy is an uncommon disorder, in which the most frequent presentation is as a single or multiple nodules. It can imitate breast cancer both clinically and radiologically. A differential diagnosis should be done in young patients with a personal history of diabetes, in order to avoid unnecessary surgical interventions. Two cases are presented that were diagnosed in our health area, as well as a review of the literature on this pathology


Subject(s)
Humans , Female , Adult , Young Adult , Fibrocystic Breast Disease/diagnostic imaging , Fibrocystic Breast Disease/surgery , Fibrocystic Breast Disease/complications , Diagnosis, Differential , Fibroadenoma/complications , Breast/diagnostic imaging , Breast/pathology , Biopsy, Fine-Needle/methods , Diabetes Mellitus/diagnosis
11.
Histopathology ; 75(6): 900-915, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31286532

ABSTRACT

AIMS: The diagnosis of radial scars/complex sclerosing lesions (RSs/CSLs) onpercutaneous biopsy carries a risk of histological underestimation. Consequently, surgical excision is often performed in order to exclude a possible associated malignancy. The aim of this study was to assess the rate of 'upgrade to carcinoma' upon subsequent surgical excision of RS/CSL cases diagnosed on vacuum-assisted large-core biopsy (VALCB). We also analysed the risk factors for upgrade in order to determine a subset of patients who could avoid surgery and benefit from conservative management with clinical and imaging follow-up. METHODS AND RESULTS: This was a retrospective observational single-centre study on 174 consecutive RS/CSL cases diagnosed on VALCB from May 2008 to October 2015. Univariate analysis was performed to identify clinical, radiological and histological risk factors for upgrade. Surgical excision was performed following VALCB diagnosis of 88 RS/CSL cases with or without associated atypia. The overall rate of surgical upgrade to carcinoma was 9.1% (8/88). None of the benign biopsies without atypia was surgically upgraded. Additional to atypia, risk factors for upgrade were non-incidental finding of the RS/CSL, the mammographic appearance, and the number of fragments obtained during the biopsy procedure (P < 0.05). CONCLUSION: We demonstrate that VALCB revealing an RS/CSL is reliable for excluding malignancy when there is no associated atypia and when radiological and histological findings are concordant. In such cases, surgery can be avoided in favour of clinical and imaging follow-up. When an RS/CSL is associated with atypia, the decision to perform surgical excision depends on other associated risk factors.


Subject(s)
Breast Neoplasms/pathology , Fibrocystic Breast Disease/pathology , Precancerous Conditions/pathology , Sclerosis/pathology , Adult , Aged , Biopsy, Large-Core Needle , Breast/diagnostic imaging , Breast/pathology , Breast/surgery , Breast Neoplasms/diagnostic imaging , Breast Neoplasms/surgery , Cicatrix/pathology , Female , Fibrocystic Breast Disease/diagnostic imaging , Fibrocystic Breast Disease/surgery , Humans , Mammography , Middle Aged , Precancerous Conditions/diagnostic imaging , Precancerous Conditions/surgery , Retrospective Studies , Risk Factors , Sclerosis/diagnostic imaging , Sclerosis/surgery
12.
Int J Surg Pathol ; 27(7): 781-787, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31046496

ABSTRACT

Microglandular adenosis (MGA) of the breast is exceedingly rare, with only a few case reports and series published to date. Previous studies have elegantly demonstrated the progression of benign MGA to atypical MGA to MGA-in situ carcinoma to invasive carcinoma and therefore suggest MGA as a possible non-obligate precursor lesion to a subset of breast carcinomas. Immunohistochemically, MGA is negative for estrogen receptor (ER), progesterone receptor (PR), and HER2-neu oncoprotein expression, and carcinomas arising in the setting of MGA are often reported to be triple negative. In this article, we present a unique case of an ER+/PR+/HER2- invasive carcinoma associated with MGA and atypical MGA. Our case highlights the diagnostic pitfall of MGA and suggests that MGA is a heterogeneous group of lesions with potential for either luminal-type or basal-type differentiation during progression to breast carcinoma.


Subject(s)
Breast Neoplasms/pathology , Breast/pathology , Carcinoma, Ductal, Breast/pathology , Fibrocystic Breast Disease/pathology , Precancerous Conditions/pathology , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Breast/diagnostic imaging , Breast Neoplasms/diagnosis , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/diagnosis , Carcinoma, Ductal, Breast/surgery , Disease Progression , Female , Fibrocystic Breast Disease/diagnosis , Fibrocystic Breast Disease/surgery , Humans , Mammography , Mastectomy , Middle Aged , Precancerous Conditions/diagnosis , Precancerous Conditions/surgery
13.
Breast ; 45: 64-69, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30884340

ABSTRACT

PURPOSE: The evaluation of the surgical margin in breast conservative surgery is a matter of general interest as such treatments are subject to the critical issue of margin status as positive surgical margins can undermine the effectiveness of the procedure. The relatively unexplored ability of millimeter-wave (mm-wave) spectroscopy to provide insight into the dielectric properties of breast tissues was investigated as a precursor to their possible use in assessment of surgical margins. METHODS: We assessed the ability of a mm-wave system with a roughly hemispherical sensitive volume of ∼3 mm radius to distinguish malignant breast lesions in prospectively and consecutively collected tumoral and non-tumoral ex-vivo breast tissue samples from 91 patients. We characterized the dielectric properties of 346 sites in these samples, encompassing malignant, fibrocystic disease and normal breast tissues. An expert pathologist subsequently evaluated all measurement sites. RESULTS: At multivariate analysis, mm-wave dielectric properties were significantly correlated to histologic diagnosis and fat content. Further, using 5-fold cross-validation in a Bayesian logistic mixed model that considered the patient as a random effect, the mm-wave dielectric properties of neoplastic tissues were significantly different from normal breast tissues, but not from fibrocystic tissue. CONCLUSION: Reliable discrimination of malignant from normal, fat-rich breast tissue to a depth compatible with surgical margin assessment requirements was achieved with mm-wave spectroscopy.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Dielectric Spectroscopy/statistics & numerical data , Margins of Excision , Mastectomy, Segmental , Adult , Aged , Aged, 80 and over , Bayes Theorem , Breast/pathology , Breast/surgery , Dielectric Spectroscopy/methods , Female , Fibrocystic Breast Disease/pathology , Fibrocystic Breast Disease/surgery , Humans , Logistic Models , Middle Aged , Multivariate Analysis , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity
15.
BMC Cancer ; 19(1): 31, 2019 Jan 08.
Article in English | MEDLINE | ID: mdl-30621638

ABSTRACT

BACKGROUND: Cystic hypersecretory carcinoma is a rare subtype of breast cancer. It is a member of cystic hypersecretory lesions, which include a series of pathological disease lineages: cystic hypersecretory hyperplasia (CHH), CHH with atypia, cystic hypersecretory carcinoma (CHC) and invasive CHC. It was found that most cystic hypersecretion lesions were in situ carcinoma, and only 19 cases of invasive cystic hypersecretion carcinoma were reported. CASE PRESENTATION: We are reporting a case of a 63-year-old female who had a lump in her left breast for 3 years. A modified radical mastectomy was done and morphological diagnosis of invasive CHC with axillary node metastasis was made. CONCLUSIONS: Owing to a smaller number of reported cases, little is known about the biological behavior, prognosis and molecular study of cystic hypersecretion lesions. Therefore, more cases with follow-up data are needed to reveal the biological behavior of this rare tumor.


Subject(s)
Breast Neoplasms/surgery , Carcinoma, Intraductal, Noninfiltrating/diagnosis , Fibrocystic Breast Disease/diagnosis , Hyperplasia/diagnosis , Breast/pathology , Breast/surgery , Breast Neoplasms/diagnosis , Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/diagnosis , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/surgery , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Intraductal, Noninfiltrating/surgery , Female , Fibrocystic Breast Disease/pathology , Fibrocystic Breast Disease/surgery , Humans , Hyperplasia/pathology , Hyperplasia/surgery , Mastectomy , Middle Aged
16.
Hum Pathol ; 82: 1-9, 2018 12.
Article in English | MEDLINE | ID: mdl-29949742

ABSTRACT

Microglandular adenosis (MA) of the breast, a benign glandular proliferation, was originally described approximately 35 years ago. The lesion is constituted by small glands, all of the same size. Glands are lined by one layer of cuboidal epithelial cells encircled by basal lamina without any evidence of interposed myoepithelial elements. Cells are positive for low-weight keratins and S-100 protein and negative for estrogen receptor, progesterone receptor, and HER-2. Since then, in the years that followed, several malignant lesions all showing microglandular architecture have been regarded either as a precursor or as an equivalent manifestation of MA. The latter has been associated with a large number of malignancies that include ductal carcinoma in situ, lobular carcinoma in situ, ademyoepithelioma, high-grade basal-like carcinoma, adenoid cystic carcinoma, matrix-producing carcinoma, invasive duct carcinoma not otherwise specified, and spindle cell carcinoma, not to mention acinic cell carcinoma. None of the above tumors were identical to MA. Differences mainly rested not only on the specific structure of the small glands but also on the cytological composition and immunohistochemical features of different lesions. Here, a review of the features of MA together with the differential diagnosis with lesions showing microglandular structure is discussed. MA shows similarities to a lesion named microglandular hamartoma/adenosis of the nasal cavity. The relation of the 2 similar lesions is discussed.


Subject(s)
Breast Neoplasms/pathology , Cell Proliferation , Fibrocystic Breast Disease/pathology , Mammary Glands, Human/pathology , Precancerous Conditions/pathology , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy , Breast Neoplasms/chemistry , Breast Neoplasms/surgery , Diagnosis, Differential , Female , Fibrocystic Breast Disease/chemistry , Fibrocystic Breast Disease/surgery , Humans , Immunohistochemistry , Mammary Glands, Human/chemistry , Mammary Glands, Human/surgery , Middle Aged , Precancerous Conditions/metabolism , Precancerous Conditions/surgery , Predictive Value of Tests
17.
J Clin Pathol ; 71(6): 546-553, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29436376

ABSTRACT

AIMS: To fully elucidate the clinicopathological features of breast carcinoma in sclerosing adenosis (SA-BC). METHODS: Clinical and histological characteristics of 206 SA-BCs from 180 patients were retrospectively evaluated. Immunohistochemical phenotype was examined. The clinicopathological relevance of the topographical pattern of SA-BCs was analysed. RESULTS: Overall, up to 46 patients (25.6%) had contralateral cancer, either SA associated or not. Of 99 cases who underwent core needle biopsy (CNB), 36 were underestimated as adenosis or atypical ductal hyperplasia at CNB, 5 invasive cases were misinterpreted as in situ carcinomas, whereas 4 ductal carcinoma in situ (DCIS) cases were overdiagnosed as invasive carcinoma. Microscopically, 163 tumours were in situ, including 136 DCIS, 19 lobular carcinomas in situ (LCIS) and 8 mixed DCIS/LCIS; of these carcinomas in situ (CIS), 37 had microinvasion. The DCIS group exhibited low, intermediate and high grades in 53.7%, 34.6% and 11.8% of cases, respectively, mostly with solid (43.4%) or cribriform (41.9%) pattern. Forty out of 43 invasive cases were invasive ductal carcinoma (IDC), mostly DCIS predominant. Immunophenotypically, luminal A phenotype was identified in 55.1%, 63.2% and 45.0% of DCIS, LCIS and IDC cases, respectively. Topographical type A group (carcinoma being entirely confined to SA, n=176) was characterised by smaller size, less invasiveness, lower grade and more frequency of luminal A immunophenotype compared with type B group (≥ 50% but not all of the carcinomatous lesion being located in SA, n=30) (all P<0.05). CONCLUSIONS: CIS, especially non-high-grade DCIS, represents the most common variant of SA-BC, and luminal A is the most predominant immunophenotype. CNB assessment might be challenging in some SA-BCs. The topographical pattern has great clinicopathological relevance. Careful evaluation of the contralateral breast and long-term follow-up for patients with SA-BC is necessary given its high prevalence of bilaterality.


Subject(s)
Biomarkers, Tumor/analysis , Breast Carcinoma In Situ/chemistry , Breast Neoplasms/chemistry , Carcinoma, Ductal, Breast/chemistry , Carcinoma, Intraductal, Noninfiltrating/chemistry , Carcinoma, Lobular/chemistry , Fibrocystic Breast Disease/chemistry , Immunohistochemistry , Immunophenotyping/methods , Sclerosis , Adult , Aged , Biomarkers, Tumor/genetics , Biopsy , Breast Carcinoma In Situ/genetics , Breast Carcinoma In Situ/pathology , Breast Carcinoma In Situ/surgery , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/genetics , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/surgery , Carcinoma, Intraductal, Noninfiltrating/genetics , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Intraductal, Noninfiltrating/surgery , Carcinoma, Lobular/genetics , Carcinoma, Lobular/pathology , Carcinoma, Lobular/surgery , Diagnostic Errors , Female , Fibrocystic Breast Disease/genetics , Fibrocystic Breast Disease/pathology , Fibrocystic Breast Disease/surgery , Humans , In Situ Hybridization, Fluorescence , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Phenotype , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Tumor Burden
18.
In. Soler Vaillant, Rómulo; Mederos Curbelo, Orestes Noel. Cirugía. Tomo III. Afecciones quirúrgicas del cuello y del tórax. La Habana, ECIMED, 2018. , ilus.
Monography in Spanish | CUMED | ID: cum-70600
19.
Histopathology ; 71(6): 859-865, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28657118

ABSTRACT

AIMS: Gender dysphoria is a diagnosis whereby an individual identifies as the opposite gender. The management of patients seeking female-to-male (FTM) transition includes hormonal therapy and surgical intervention, including mastectomy. The aim of this study was to characterize the immunohistological findings in resection specimens from FTM patients. METHODS AND RESULTS: We reviewed 68 cases (67 patients, one with re-excision) of FTM breast tissue resection by collecting clinical data, reviewing breast imaging and pathology reports (gross fibrous density, specimen weight, and number of cassettes submitted), and reviewing pathology slides [number of tissue pieces submitted, number of terminal duct lobule units (TDLUs), and the presence of histological findings]. Significant histological findings were present in 51 of 68 (75.0%) cases, including one case (1.5%) of flat epithelial atypia. Fibrocystic changes were the most common finding (27/68, 39.7%), followed by gynaecomastoid change, fibrotic stage, (22/68, 32.4%), and fibroadenomatoid change (11/68, 16.2%). Fibrocystic change was associated with increased numbers of TDLUs, and gynaecomastoid change was associated with lower body mass index and decreased numbers of TDLUs. Gynaecomastoid change showed a moderate proportion of luminal epithelial cells with strong-intensity immunohistochemical staining for oestrogen receptor, progesterone receptor, and androgen receptor, and a three-layered epithelium demonstrated by the use of cytokeratin 5/6 immunohistochemistry. CONCLUSIONS: We identified gynaecomastoid change at a significantly higher rate than previously reported in female patients. We support the continued gross and histological evaluation of FTM specimens in light of the identification of atypia in one case.


Subject(s)
Fibrocystic Breast Disease/pathology , Gender Dysphoria/pathology , Hyperplasia/pathology , Adult , Breast/pathology , Breast/surgery , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Fibrocystic Breast Disease/surgery , Gender Dysphoria/surgery , Humans , Hyperplasia/surgery , Male , Mastectomy , Middle Aged , Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Sex Reassignment Surgery , Transgender Persons , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL